Filing Details
- Accession Number:
- 0001562180-25-003212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-18 16:31:45
- Reporting Period:
- 2025-04-17
- Filing Date:
- 2025-04-18
- Accepted Time:
- 2025-04-18 16:31:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-17 | 11,000 | $117.76 | 47,781 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-04-17 | 400 | $280.35 | 47,381 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-04-17 | 2,016 | $282.92 | 45,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-04-17 | 5,488 | $283.83 | 39,877 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-04-17 | 3,096 | $284.69 | 36,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-04-17 | 11,000 | $0.00 | 11,000 | $117.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,000 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
- This transaction was executed in multiple trades at prices ranging from $279.95 to $280.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $282.36 to $283.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $283.37 to $284.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $284.38 to $285.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
